211 related articles for article (PubMed ID: 11248133)
1. Physiological modeling reveals novel pharmacokinetic behavior for inhaled octamethylcyclotetrasiloxane in rats.
Andersen ME; Sarangapani R; Reitz RH; Gallavan RH; Dobrev ID; Plotzke KP
Toxicol Sci; 2001 Apr; 60(2):214-31. PubMed ID: 11248133
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and disposition of [
Domoradzki JY; Sushynski CM; Sushynski JM; McNett DA; Van Landingham C; Plotzke KP
Toxicol Lett; 2017 Oct; 279 Suppl 1():98-114. PubMed ID: 28511864
[TBL] [Abstract][Full Text] [Related]
3. Closed-chamber inhalation pharmacokinetic studies with hexamethyldisiloxane in the rat.
Dobrev ID; Reddy MB; Plotzke KP; Varaprath S; McNett DA; Durham J; Andersen ME
Inhal Toxicol; 2003 May; 15(6):589-617. PubMed ID: 12692732
[TBL] [Abstract][Full Text] [Related]
4. Assessing kinetic determinants for metabolism and oral uptake of octamethylcyclotetrasiloxane (D4) from inhalation chamber studies.
Dobrev ID; Nong A; Liao KH; Reddy MB; Plotzke KP; Andersen ME
Inhal Toxicol; 2008 Feb; 20(4):361-73. PubMed ID: 18302045
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of a recirculating mobile lipid pool description into the cyclic volatile siloxane (cVMS) PBPK model captures terminal clearance of D
Campbell J; Andersen M; Gentry R; Landingham CV; Clewell H
Toxicol Lett; 2023 Feb; 375():29-38. PubMed ID: 36596351
[TBL] [Abstract][Full Text] [Related]
6. Physiological modeling of inhalation kinetics of octamethylcyclotetrasiloxane in humans during rest and exercise.
Reddy MB; Andersen ME; Morrow PE; Dobrev ID; Varaprath S; Plotzke KP; Utell MJ
Toxicol Sci; 2003 Mar; 72(1):3-18. PubMed ID: 12604830
[TBL] [Abstract][Full Text] [Related]
7. Development of an integrated multi-species and multi-dose route PBPK model for volatile methyl siloxanes - D4 and D5.
McMullin TS; Yang Y; Campbell J; Clewell HJ; Plotzke K; Andersen ME
Regul Toxicol Pharmacol; 2016 Feb; 74 Suppl():S1-13. PubMed ID: 26724268
[TBL] [Abstract][Full Text] [Related]
8. Dose-response modeling of cytochrome p450 induction in rats by octamethylcyclotetrasiloxane.
Sarangapani R; Teeguarden J; Plotzke KP; McKim JM; Andersen ME
Toxicol Sci; 2002 Jun; 67(2):159-72. PubMed ID: 12011475
[TBL] [Abstract][Full Text] [Related]
9. Inhalation toxicology of octamethylcyclotetrasiloxane (D4) following a 3-month nose-only exposure in Fischer 344 rats.
Burns-Naas LA; Meeks RG; Kolesar GB; Mast RW; Elwell MR; Hardisty JF; Thevenaz P
Int J Toxicol; 2002; 21(1):39-53. PubMed ID: 11936898
[TBL] [Abstract][Full Text] [Related]
10. Inhalation dosimetry modeling with decamethylcyclopentasiloxane in rats and humans.
Reddy MB; Dobrev ID; McNett DA; Tobin JM; Utell MJ; Morrow PE; Domoradzki JY; Plotzke KP; Andersen ME
Toxicol Sci; 2008 Oct; 105(2):275-85. PubMed ID: 18583370
[TBL] [Abstract][Full Text] [Related]
11. Route-specific differences in distribution characteristics of octamethylcyclotetrasiloxane in rats: analysis using PBPK models.
Sarangapani R; Teeguarden J; Andersen ME; Reitz RH; Plotzke KP
Toxicol Sci; 2003 Jan; 71(1):41-52. PubMed ID: 12520074
[TBL] [Abstract][Full Text] [Related]
12. Disposition of radioactivity in fischer 344 rats after single and multiple inhalation exposure to [(14)C]Octamethylcyclotetrasiloxane ([(14)C]D(4)).
Plotzke KP; Crofoot SD; Ferdinandi ES; Beattie JG; Reitz RH; McNett DA; Meeks RG
Drug Metab Dispos; 2000 Feb; 28(2):192-204. PubMed ID: 10640518
[TBL] [Abstract][Full Text] [Related]
13. Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans.
Andersen ME; Clewell HJ; Gargas ML; MacNaughton MG; Reitz RH; Nolan RJ; McKenna MJ
Toxicol Appl Pharmacol; 1991 Mar; 108(1):14-27. PubMed ID: 1900959
[TBL] [Abstract][Full Text] [Related]
14. Biological relevance of effects following chronic administration of octamethylcyclotetrasiloxane (D4) in Fischer 344 rats.
Dekant W; Scialli AR; Plotzke K; Klaunig JE
Toxicol Lett; 2017 Oct; 279 Suppl 1():42-53. PubMed ID: 28109826
[TBL] [Abstract][Full Text] [Related]
15. Refinement of the oral exposure description in the cyclic siloxane PBPK model for rats and humans: Implications for exposure assessment.
Campbell JL; Andersen ME; Van Landingham C; Gentry R; Jensen E; Domoradzki JY; Clewell HJ
Toxicol Lett; 2017 Oct; 279 Suppl 1():125-135. PubMed ID: 28408153
[TBL] [Abstract][Full Text] [Related]
16. Are highly lipophilic volatile compounds expected to bioaccumulate with repeated exposures?
Andersen ME; Reddy MB; Plotzke KP
Toxicol Lett; 2008 Jun; 179(2):85-92. PubMed ID: 18513896
[TBL] [Abstract][Full Text] [Related]
17. Effects of chronic exposure to octamethylcyclotetrasiloxane and decamethylcyclopentasiloxane in the aging female Fischer 344 rat.
Jean PA; Sloter ED; Plotzke KP
Toxicol Lett; 2017 Oct; 279 Suppl 1():54-74. PubMed ID: 28842205
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of octamethylcyclotetrasiloxane (D(4)) after exposure to silicones by inhalation and implantation.
Luu HM; Hutter JC
Environ Health Perspect; 2001 Nov; 109(11):1095-101. PubMed ID: 11712992
[TBL] [Abstract][Full Text] [Related]
19. Toxicology and humoral immunity assessment of octamethylcyclotetrasiloxane (D4) following a 28-day whole body vapor inhalation exposure in Fischer 344 rats.
Klykken PC; Galbraith TW; Kolesar GB; Jean PA; Woolhiser MR; Elwell MR; Burns-Naas LA; Mast RW; McCay JA; White KL; Munson AE
Drug Chem Toxicol; 1999 Nov; 22(4):655-77. PubMed ID: 10536755
[TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacokinetic studies of
Schmitt BG; Tobin J; McNett DA; Kim J; Durham J; Plotzke KP
Toxicol Lett; 2023 Jan; 373():13-21. PubMed ID: 36332816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
